Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) is seeing its shareholders get nothing but coal for Christmas this year. The stock is the largest loser on the NASDAQ today with a drop of nearly 14% to $4.99. What is interesting here is …
Biovail also recently struck a deal with Alexza Pharmaceuticals ALXA.O to develop and commercialize its inhaled treatment for agitation. Shares of Biovail were up 21 Canadian cents at C$15.58 on the Toronto Stock Exchange on …
TLSR: Go ahead with another stock. SB: Alexza Pharmaceuticals Inc. (ALXA:NASDAQ) has a product, Adasuve (loxapine), for extreme agitation. It is well known, and the Europeans have used it for years and years. If a patient …
BOSTON, March 26 (Reuters) - Alexza Pharmaceuticals Inc. ALXA.O reported positive clinical trial results for two of its experimental drugs on Monday, sending its shares soaring more than 48 percent. The Palo Alto, California-based …
As we drive through the western-most province, Alxa League (pron. Alashan), there are tell-tale ... What you do have is too much stock for the land that there is. So the carrying capacity of the land is much lower than the stock there actually is.
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) was downgraded to Neutral from Buy at Roth Capital. Allergan Inc. …
In a report published Wednesday, Piper Jaffray analyst Charles C. Duncan upgraded the rating on Alexza …
[ID:nBNG230203] ALEXZA PHARMACEUTICALS INC ALXA.O, $2.23, down 23.2 pct The company said preliminary ... on the Dow component with an “underweight” rating, saying its stock looked expensive on capital metrics against its global …
ALXA), Guava Technologies(acquired by Millipore), Ambit Biosciences, Saegis Pharmaceuticals and Cell Biosciences.Dr. Tandon has been a venture capitalist in Silicon Valley for past decade plus and was Managing Director, Lumira/MDS …